These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32084590)

  • 1. Response to Behrens and Edwards: Atovaquone-proguanil exposure in pregnancy should not be condemned from current evidence.
    Gutman JR; Tan KR
    Travel Med Infect Dis; 2020; 34():101599. PubMed ID: 32084590
    [No Abstract]   [Full Text] [Related]  

  • 2. Atovaquone-proguanil exposure in pregnancy should not be condemned from current evidence.
    Behrens R; Edwards P
    Travel Med Infect Dis; 2020; 34():101559. PubMed ID: 31962169
    [No Abstract]   [Full Text] [Related]  

  • 3. A survey on outcomes of accidental atovaquone-proguanil exposure in pregnancy.
    Tan KR; Fairley JK; Wang M; Gutman JR
    Malar J; 2018 May; 17(1):198. PubMed ID: 29764439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The safety of atovaquone-proguanil for the prevention and treatment of malaria in pregnancy: A systematic review.
    Andrejko KL; Mayer RC; Kovacs S; Slutsker E; Bartlett E; Tan KR; Gutman JR
    Travel Med Infect Dis; 2019; 27():20-26. PubMed ID: 30654041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atovaquone-proguanil: report from the CDC expert meeting on malaria chemoprophylaxis (II).
    Boggild AK; Parise ME; Lewis LS; Kain KC
    Am J Trop Med Hyg; 2007 Feb; 76(2):208-23. PubMed ID: 17297027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics and pharmacodynamics of atovaquone and proguanil for the treatment of uncomplicated falciparum malaria in third-trimester pregnant women.
    Na-Bangchang K; Manyando C; Ruengweerayut R; Kioy D; Mulenga M; Miller GB; Konsil J
    Eur J Clin Pharmacol; 2005 Sep; 61(8):573-82. PubMed ID: 16041597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of atovaquone-proguanil during pregnancy.
    Mayer RC; Tan KR; Gutman JR
    J Travel Med; 2019 Jun; 26(4):. PubMed ID: 30544231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the Plasmodium falciparum cytochrome b gene are associated with delayed parasite recrudescence in malaria patients treated with atovaquone-proguanil.
    Sutherland CJ; Laundy M; Price N; Burke M; Fivelman QL; Pasvol G; Klein JL; Chiodini PL
    Malar J; 2008 Nov; 7():240. PubMed ID: 19021900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-marketing surveillance: adverse events during long-term use of atovaquone/proguanil for travelers to malaria-endemic countries.
    Overbosch D
    J Travel Med; 2003 May; 10 Suppl 1():S16-20; discussion S21-3. PubMed ID: 12737756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atovaquone and proguanil hydrochloride: a review of nonclinical studies.
    Pudney M; Gutteridge W; Zeman A; Dickins M; Woolley JL
    J Travel Med; 1999 May; 6 Suppl 1():S8-12. PubMed ID: 23573546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of an interaction between artesunate and atovaquone--proguanil.
    van Vugt M; Edstein MD; Proux S; Lay K; Ooh M; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 1999 Aug; 55(6):469-74. PubMed ID: 10492061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and meta-analysis of the effectiveness and safety of atovaquone proguanil (Malarone) for chemoprophylaxis against malaria.
    Nakato H; Vivancos R; Hunter PR
    J Antimicrob Chemother; 2007 Nov; 60(5):929-36. PubMed ID: 17848375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of atovaquone/proguanil compared with mefloquine for treatment of acute Plasmodium falciparum malaria in Thailand.
    Looareesuwan S; Wilairatana P; Chalermarut K; Rattanapong Y; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):526-32. PubMed ID: 10348224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged protection provided by a single dose of atovaquone-proguanil for the chemoprophylaxis of Plasmodium falciparum malaria in a human challenge model.
    Deye GA; Miller RS; Miller L; Salas CJ; Tosh D; Macareo L; Smith BL; Fracisco S; Clemens EG; Murphy J; Sousa JC; Dumler JS; Magill AJ
    Clin Infect Dis; 2012 Jan; 54(2):232-9. PubMed ID: 22052893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mefloquine for preventing malaria during travel to endemic areas.
    Tickell-Painter M; Maayan N; Saunders R; Pace C; Sinclair D
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006491. PubMed ID: 29083100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atovaquone and proguani hydrochloride compared with chloroquine or pyrimethamine/sulfodaxine for treatment of acute Plasmodium falciparum malaria in Peru.
    Llanos-Cuentas A; Campos P; Clendenes M; Canfield CJ; Hutchinson DB
    Braz J Infect Dis; 2001 Apr; 5(2):67-72. PubMed ID: 11493411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Malarone Clinical Trials Study Group.
    Looareesuwan S; Chulay JD; Canfield CJ; Hutchinson DB
    Am J Trop Med Hyg; 1999 Apr; 60(4):533-41. PubMed ID: 10348225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team.
    Høgh B; Clarke PD; Camus D; Nothdurft HD; Overbosch D; Günther M; Joubert I; Kain KC; Shaw D; Roskell NS; Chulay JD;
    Lancet; 2000 Dec; 356(9245):1888-94. PubMed ID: 11130385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
    McGready R; Stepniewska K; Edstein MD; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2003 Oct; 59(7):545-52. PubMed ID: 12955371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.